Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causal Effects of Artificially Sweetened Foods on Chronic Pain Mediated by Gut Microbiota: A Mendelian Randomization Study.

Food science & nutrition·2025
Same author

Artificially Sweetened Food Mediates the Perception of Chronic Pain in Individuals With Neuroticism Traits: A Mendelian Randomization Study.

Brain and behavior·2025
Same author

CBL/Cbl-b mediates Fas degradation to reduce neuronal damage in experimental autoimmune encephalomyelitis.

Scandinavian journal of immunology·2024
Same author

Causal Effects of Sleep Quality on Primary Headache and the Mediation via Gut Microbiota: A Mendelian Randomization Study.

Brain and behavior·2024
Same author

5-HMF attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis mice by inhibiting the MIF-CD74 interaction.

Acta biochimica et biophysica Sinica·2023
Same author

Chrysophanol Ameliorates Hemin-Induced Oxidative Stress and Endoplasmic Reticulum Stress by Regulating MicroRNA-320-5p/Wnt3a Pathway in HT22 Cells.

Oxidative medicine and cellular longevity·2022

Related Experiment Video

Updated: Jun 24, 2025

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

3.0K

Hederagenol improves multiple sclerosis by modulating Th17 cell differentiation.

Dongsheng Guan1, Yingxia Li2, Xu Zhao3

  • 1Department of Neurology, the Second Clinical Medical College, Henan University of Traditional Chinese Medicine, Zhengzhou, China.

IUBMB Life
|June 5, 2024
PubMed
Summary

Hederagenol (Hed) alleviates multiple sclerosis (MS) symptoms in mice by reducing harmful Th17 cells. This compound targets the RORγt promoter, offering a potential new treatment strategy for MS.

Keywords:
EAEHederagenolTh17 differentiationmultiple sclerosis

More Related Videos

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.5K
Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
12:08

Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

Published on: November 15, 2024

487

Related Experiment Videos

Last Updated: Jun 24, 2025

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

3.0K
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.5K
Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
12:08

Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

Published on: November 15, 2024

487

Area of Science:

  • Neuroimmunology
  • Autoimmune Diseases
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is a debilitating autoimmune disease characterized by inflammation and neurodegeneration.
  • T helper 17 (Th17) cells play a crucial role in MS pathogenesis by producing pro-inflammatory cytokine IL-17.
  • Hederagenol (Hed), a natural compound, has shown potential in modulating IL-17, but its specific role in MS requires elucidation.

Purpose of the Study:

  • To investigate the therapeutic potential of Hederagenol (Hed) in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS.
  • To determine if Hed ameliorates MS by modulating Th17 cell differentiation.
  • To identify potential new therapeutic targets for MS treatment.

Main Methods:

  • EAE mouse model induction and treatment with Hederagenol (Hed).
  • Assessment of clinical symptoms, spinal cord inflammation, demyelination, and nerve damage.
  • Flow cytometry and quantitative PCR/Western blot to analyze T cell subsets and RORγt expression.
  • Chromatin immunoprecipitation to assess RORγt promoter activity.

Main Results:

  • Hed treatment significantly reduced clinical symptoms, spinal cord inflammation, demyelination, and nerve damage in EAE mice.
  • Hed administration decreased the number of Th17 cells in both the spinal cord and spleen.
  • Hed lowered RORγt levels and RORγt promoter activity, indicating modulation of Th17 differentiation.
  • Overexpression of RORγt counteracted the inhibitory effects of Hed on Th17 differentiation.

Conclusions:

  • Hederagenol (Hed) effectively ameliorates EAE symptoms and neuropathology.
  • Hed exerts its therapeutic effects by inhibiting Th17 cell differentiation via RORγt pathway modulation.
  • Hed represents a promising therapeutic agent for MS, targeting Th17-mediated neuroinflammation.